Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Namodenoson

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Can-Fite’s Namodenoson Treats Esophageal Varices in Cirrhosis
    Can-Fite’s Namodenoson Treats Esophageal Varices in Cirrhosis

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3149846/0/en/Can-Fite-Reports-Complete-Resolution-of-Esophageal-Varices-in-Decompensated-Cirrhosis-Patient-Treated-with-Namodenoson.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Can-Fite's Namodenoson Hits 50% Enrollment in Phase 2a Study
    Can-Fite's Namodenoson Hits 50% Enrollment in Phase 2a Study

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3123927/0/en/Pancreatic-Cancer-Phase-2a-Study-with-Can-Fite-s-Namodenoson-Achieved-Over-50-Enrollment-Milestone.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    U.S. Medical Centers Seek Authorization for Namodenoson
    U.S. Medical Centers Seek Authorization for Namodenoson

    17 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/17/3063424/0/en/Following-FDA-Compassionate-Use-Approval-for-Pancreatic-Carcinoma-with-Can-Fite-s-Namodenoson-Leading-U-S-Medical-Centers-Seek-Authorization-for-their-Patients.html

    GLOBENEWSWIRE
    17 Apr 2025
    Share Share
    Can-Fite: FDA Approves Use of Namodenoson in Pancreatic Cancer
    Can-Fite: FDA Approves Use of Namodenoson in Pancreatic Cancer

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044514/0/en/Can-Fite-FDA-Approved-Compassionate-Use-Treatment-with-Namodenoson-in-a-Pancreatic-Cancer-Patient.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share
    Can-Fite Publishes Namodenoson Benefits In Liver Cancer
    Can-Fite Publishes Namodenoson Benefits In Liver Cancer

    03 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/03/3035375/0/en/Can-Fite-Innovative-Publication-Namodenoson-in-Liver-Cancer-Treatment-Alongside-with-Cardiac-Liver-and-Neurological-Benefits.html

    GLOBENEWSWIRE
    03 Mar 2025
    Share Share
    Can-Fite’s Namodenoson Clears Decompensated Liver Cirrhosis
    Can-Fite’s Namodenoson Clears Decompensated Liver Cirrhosis

    18 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/18/3027671/0/en/Disappearance-of-Decompensated-Liver-Cirrhosis-Episodes-After-Treatment-with-Can-Fite-s-Namodenoson.html

    GLOBENEWSWIRE
    18 Feb 2025
    Share Share